Janumet is a combination of Sitagliptin and Metformin HCL, used to improve blood sugar control in adults with type 2 diabetes. This combination helps by decreasing glucose production in the liver and increasing the body's sensitivity to insulin.
Indications: Type 2 diabetes mellitus.
Dosage: Dosage varies based on individual patient needs, typically taken twice daily with meals.
Side Effects: Lactic acidosis (rare), diarrhea, nausea, hypoglycemia, upper respiratory infection.
Precautions: Not recommended for patients with severe renal impairment or metabolic acidosis. Monitor kidney function regularly.
Storage: Store at room temperature, protected from moisture and heat.
| Dosage Form | Oral Tablet |
| Route Of Administration | Oral |
| Composition | Sitagliptin Phosphate Metformin Hcl |
| Tablet Shape | Round |
| Storage Conditions | Store At Room Temperature |
| Strength | 50mg, 1000 Mg |
| Dosage | As Directed By Physican |
| Medicine Type | Allopathic |
| Shelf Life | Check Product Level |
| Drug Interactions | May Interact With Other Antidiabetic Drugs |
| Indication | Type 2 Diabetes Mellitus |
| Application | Clinic, Hospitals |
| Benefits | No Side Effects, Increasing Insulin Release, High Strength |
| Packaging | Blister Packs, Bottles |
| Quantity | 56 Tablets |
| Supply By | Medicina Overseas Private Limited |
| Country Of Origin | India |
